rimactan 300 mg
sandoz gmbh - rifampicin - kapsel, hard - 300 mg
rimactan 300 mg
2care4 aps - rifampicin - kapsel, hard - 300 mg
rimcure
sandoz - københavn - rifampicin / isoniazid / pyrazinamid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg
trimonil retard 300 mg
orifarm as - karbamazepin - depottablett - 300 mg
trimonil retard 300 mg
orifarm as - karbamazepin - depottablett - 300 mg
rimstar
2care4 aps - rifampicin / isoniazid / pyrazinamid / etambutolhydroklorid - tablett, filmdrasjert - 150 mg / 75 mg / 400 mg / 275 mg
rimactan 300 mg
orifarm as - rifampicin - kapsel, hard - 300 mg
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
gavreto
roche registration gmbh - pralsetinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
tivicay
viiv healthcare bv - dolutegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.